HOLOGIC INC
HOLXHealthcare · X-Ray Apparatus & Tubes & Related Irradiation Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $4.10B | $4.03B | $4.03B | $4.86B | $5.63B | $3.78B |
| Operating income | $714.3M | $882.6M | $668.4M | $1.64B | $2.48B | $1.10B |
| Net income | $565.7M | $789.5M | $456.0M | $1.30B | $1.87B | $1.12B |
| Total assets | $9.01B | $9.16B | $9.14B | $9.07B | $8.92B | $7.20B |
| Total liabilities | — | — | — | — | — | — |
| Equity | $5.05B | $5.13B | $5.02B | $4.88B | $4.22B | $2.71B |
| EPS (diluted) | $2.49 | $3.32 | $1.83 | $5.13 | $7.21 | $4.21 |
| Shares out. | 222.9M | 226.9M | 240.0M | 245.8M | 251.4M | 257.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 17.4%
- Net margin
- 13.8%
- Return on equity
- 11.2%
- Return on assets
- 6.3%
- Return on capital (ROCE)
- 8.9%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $22.65
- Revenue growth (YoY)
- 1.7%
- Net income growth (YoY)
- −28.3%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −5.5%clean
- Piotroski F-Score
- 6/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 4 good- Operating margin is positive
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Capital Management LlcPassive (13G)Apr 30, 2026
- Vanguard Group IncPassive (13G)Mar 27, 2026
- T. Rowe Price Investment Management, Inc.Passive (13G)Feb 17, 2026
- Blackrock, Inc.Passive (13G)Apr 17, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Mitchell Essex DOfficer — Chief Operating Officer | Apr 7, 2026 | D | 77,694 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Mar 31, 2026 | 8.2M | 2.3 | +15.5% |
| Mar 13, 2026 | 7.1M | 2.4 | -14.5% |
| Feb 27, 2026 | 8.3M | 3.8 | +71.7% |
| Feb 13, 2026 | 4.8M | 1.8 | +16.5% |
| Jan 30, 2026 | 4.1M | 1.6 | +9.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Regulation FD disclosureApr 7, 2026
- Director / officer change · Other material eventApr 6, 2026
- Shareholder vote · Other material eventFeb 6, 2026
- Results of operationsJan 29, 2026
- Other material eventJan 26, 2026
- Director / officer changeNov 7, 2025
- Results of operationsNov 3, 2025
- Entered a material agreement · Director / officer change · Other material eventOct 21, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SCHEDULE 13GApr 30, 2026
- 15-12GApr 17, 2026
- EFFECTApr 10, 2026
- EFFECTApr 10, 2026
- 4PRIMARY DOCUMENTApr 9, 2026
- 4PRIMARY DOCUMENTApr 9, 2026
- 4PRIMARY DOCUMENTApr 9, 2026
- 4PRIMARY DOCUMENTApr 9, 2026
- 4PRIMARY DOCUMENTApr 9, 2026
- 4PRIMARY DOCUMENTApr 9, 2026
- 4PRIMARY DOCUMENTApr 9, 2026
- 4PRIMARY DOCUMENTApr 9, 2026
- 4PRIMARY DOCUMENTApr 9, 2026
- 4PRIMARY DOCUMENTApr 9, 2026
- 4PRIMARY DOCUMENTApr 9, 2026
Event-driven situations (3)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.